Paraoxonase: A multifaceted biomolecule

被引:114
作者
Goswami, Binita [1 ]
Tayal, Devika [2 ]
Gupta, Nikhil [3 ]
Mallika, V. [1 ]
机构
[1] GB Pant Hosp, Dept Biochem, New Delhi, India
[2] Lady Hardinge Med Coll & Hosp, Dept Biochem, New Delhi, India
[3] Maulana Azad Med Coll, Dept Surg, New Delhi, India
关键词
Paraoxonase; Polymorphisms; Cancer; Coronary artery disease; Organophosphorus poisoning; Mixed connective tissue disorders; Cirrhosis; Hepatitis; Polycystic ovarian syndrome; Endometriosis; Lead poisoning; HUMAN SERUM PARAOXONASE; POLYCYSTIC-OVARY-SYNDROME; APOLIPOPROTEIN-A-I; DENSITY-LIPOPROTEIN OXIDATION; ARYLESTERASE ACTIVITIES; DIABETES-MELLITUS; PON1; ACTIVITY; RISK-FACTOR; ANTIOXIDANT ENZYME; INSULIN-RESISTANCE;
D O I
10.1016/j.cca.2009.09.025
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Background: Paraoxonase enzyme was first identified as a protective barrier against organophosphorus poisoning. After painstaking research spanning the last three decades, the knowledge about this enzyme has increased immensely. The present review attempts to elaborate the role of paraoxonase enzyme in normal physiology as well as provide an overview of the various disorders in which the enzyme may have a role in etiopathogenesis. Methods: The literature was searched from the websites of the National Library of Medicine (http://www.ncbi.nim.nih.gov/) and Pub Med Central, the U.S. National Library of Medicine's digital archive of life sciences journal literature. Results: Paraoxonase acts as an important antioxidant enzyme against oxidative stress. The enzyme has been implicated in the pathogenesis of a number of disorders including cardiovascular disorders, cancers etc. Conclusions: A better understanding of the molecular mechanism of the enzyme along with the regulatory circuits will help us to utilize agonists to potentiate the anti oxidant actions of the enzyme. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 160 条
[1]
SERUM PARAOXONASE ACTIVITY, CONCENTRATION, AND PHENOTYPE DISTRIBUTION IN DIABETES-MELLITUS AND ITS RELATIONSHIP TO SERUM-LIPIDS AND LIPOPROTEINS [J].
ABBOTT, CA ;
MACKNESS, MI ;
KUMAR, S ;
BOULTON, AJ ;
DURRINGTON, PN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1812-1818
[2]
ADKINS S, 1993, AM J HUM GENET, V52, P598
[3]
Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus [J].
Agachan, B ;
Yilmaz, H ;
Karaali, Z ;
Isbir, T .
CELL BIOCHEMISTRY AND FUNCTION, 2004, 22 (03) :163-168
[4]
Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor [J].
Ahmed, Z ;
Ravandi, A ;
Maguire, GF ;
Emili, A ;
Draganov, D ;
La Du, BN ;
Kuksis, A ;
Connelly, PW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) :24473-24481
[5]
Akcay M N, 2003, Hepatogastroenterology, V50 Suppl 2, pccxxv
[6]
Akcay M N, 2003, Hepatogastroenterology, V50 Suppl 2, pcclxxiii
[7]
Gin → Arg 191 polymorphism of paraoxonase and Parkinson's disease [J].
Akhmedova, S ;
Anisimov, S ;
Yakimovsky, A ;
Schwartz, E .
HUMAN HEREDITY, 1999, 49 (03) :178-180
[8]
Non-alcoholic fatty liver disease [J].
Alba, LM ;
Lindor, K .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) :977-986
[9]
ALDRIDGE WN, 1953, BIOCHEM J, V53, P7
[10]
Aldridge WN, 1953, BIOCHEM J, V53